We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Urology

Journal Scan / Research · April 12, 2021

Risk of Adverse Pathology at Prostatectomy in the Era of MRI and Targeted Biopsies

Urologic Oncology: Seminars and Original Investigations

 

Additional Info

Disclosure statements are available on the authors' profiles:

Urologic Oncology: Seminars and Original Investigations
Risk of Adverse Pathology at Prostatectomy in the Era of MRI and Targeted Biopsies; Rethinking Active Surveillance for Intermediate-Risk Prostate Cancer Patients
Urol. Oncol 2021 Mar 15;[EPub Ahead of Print], JB Bloom, MA Daneshvar, AH Lebastchi, M Ahdoot, SA Gold, G Hale, S Mehralivand, T Sanford, V Valera, BJ Wood, PL Choyke, MJ Merino, B Turkbey, HL Parnes, PA Pinto

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading